Clinical features and outcome of children with hereditary spherocytosis
dc.authorid | Gül Nihal Özdemir / 0000-0002-3204-4353 | en_US |
dc.authorscopusid | Gül Nihal Özdemir / 34067792800 | |
dc.authorwosid | Gül Nihal Özdemir / AAO-9962-2020 | |
dc.contributor.author | Kılıç, Mehmet A | |
dc.contributor.author | Özdemir, Gül Nihal | |
dc.contributor.author | Tahtakesen, Tuba Nur | |
dc.contributor.author | Gökçe, Müge G. | |
dc.contributor.author | Uysalol, Ezgi Paslı | |
dc.contributor.author | Bayram, Cengiz | |
dc.contributor.author | Ayçiçek, Ali | |
dc.contributor.author | Aydo?an, Gönül | |
dc.date.accessioned | 2021-06-16T06:11:43Z | |
dc.date.available | 2021-06-16T06:11:43Z | |
dc.date.issued | 2021 | en_US |
dc.department | İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | Objective: The aim of this study was to evaluate the demographics, clinical, and laboratory findings and treatment responses of patients with hereditary spherocytosis (HS). Materials and Methods: Data of children with HS were examined. Diagnosis was based on clinical history, physical examination, family history, presence of spherocytes on peripheral blood smear, and osmotic fragility test. Results: A total of 101 patients were included. The median (range) age at diagnosis was 38.0 (1 to 188) months. Mild, moderate, and severe forms of HS were present in 29 (28.7%), 15 (14.9%), and 57 (56.4%) patients, respectively. Family history was available in 73 patients and 56 of these (76.7%) had a positive family history for HS. Forty-five (44.5%) patients needed regular transfusions and all of these had severe disease. Although most patients did not require transfusion postsplenectomy, 2 of 45 (4.4%) patients continued to require transfusion. Transfusion dependence was significantly (P<0.001) higher in patients with severe spherocytosis. Conclusions: In HS, splenomegaly, pallor, and jaundice are the most common clinical features. Splenectomy dramatically reduces hemolysis in most cases and virtually abolishes further requirement for transfusion. | en_US |
dc.identifier.citation | Kiliç, M. A., Özdemir, G. N., Tahtakesen, T. N., Gökçe, M., Uysalol, E. P., Bayram, C., ... & Aydoğan, G. (2021). Clinical Features and Outcome of Children With Hereditary Spherocytosis. Journal of Pediatric Hematology/oncology. | en_US |
dc.identifier.doi | 10.1097/MPH.0000000000002211 | en_US |
dc.identifier.issn | 1077-4114 | en_US |
dc.identifier.pmid | 34054043 | en_US |
dc.identifier.scopus | 2-s2.0-85107450404 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.uri | https://doi.org/10.1097/MPH.0000000000002211 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/1800 | |
dc.identifier.wos | WOS:000760391300012 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Özdemir, Gül Nihal | |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams and Wilkins | en_US |
dc.relation.ispartof | Journal of Pediatric Hematology/Oncology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Children | en_US |
dc.subject | Hemolytic Anemia | en_US |
dc.subject | Hereditary Spherocytosis | en_US |
dc.subject | Splenectomy | en_US |
dc.title | Clinical features and outcome of children with hereditary spherocytosis | en_US |
dc.type | Article | en_US |